Using an in vitro co-culture system, we showed that METhigh/PD-L1high Hs746T (gastric cancer) cells suppressed immune cell function, which was partially recovered by anti-PD-L1 blocking antibody and the clinically administered MET inhibitor crizotinib. This evidence concerns the gene MET and gastric cancer.